Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gynecology

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    August 2019
  1. ZENG YT, Liu XF, Yang WT, Zheng PS, et al
    REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0906.
    PubMed     Text format     Abstract available


  2. HAN Y, Kim B, Cho U, Park IS, et al
    Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0949.
    PubMed     Text format     Abstract available


    July 2019
  3. HAN X, Ren C, Yang T, Qiao P, et al
    Negative regulation of AMPKalpha1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.
    Oncogene. 2019 Jul 29. pii: 10.1038/s41388-019-0898.
    PubMed     Text format     Abstract available


  4. KLEINSCHMIDT EG, Miller NLG, Ozmadenci D, Tancioni I, et al
    Rgnef promotes ovarian tumor progression and confers protection from oxidative stress.
    Oncogene. 2019 Jul 15. pii: 10.1038/s41388-019-0881.
    PubMed     Text format     Abstract available


  5. HARDY LR, Pergande MR, Esparza K, Heath KN, et al
    Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
    Oncogene. 2019 Jul 11. pii: 10.1038/s41388-019-0842.
    PubMed     Text format     Abstract available


  6. CHEN X, Mangala LS, Mooberry L, Bayraktar E, et al
    Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
    Oncogene. 2019 Jul 9. pii: 10.1038/s41388-019-0862.
    PubMed     Text format     Abstract available


  7. MAJEM B, Parrilla A, Jimenez C, Suarez-Cabrera L, et al
    MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.
    Oncogene. 2019 Jul 5. pii: 10.1038/s41388-019-0860.
    PubMed     Text format     Abstract available


    May 2019
  8. CAO T, Jiang Y, Wang Z, Zhang N, et al
    H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
    Oncogene. 2019 May 15. pii: 10.1038/s41388-019-0808.
    PubMed     Text format     Abstract available


    April 2019
  9. HONG S, Xu J, Li Y, Andrade J, et al
    Topoisomerase IIbeta-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.
    Oncogene. 2019;38:3274-3287.
    PubMed     Text format     Abstract available


    March 2019
  10. JEONG KJ, Park SY, Cho KH, Sohn JS, et al
    Correction: The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Oncogene. 2019 Mar 29. pii: 10.1038/s41388-019-0769.
    PubMed     Text format     Abstract available


    February 2019
  11. JOHN B, Naczki C, Patel C, Ghoneum A, et al
    Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    Oncogene. 2019 Feb 14. pii: 10.1038/s41388-019-0728.
    PubMed     Text format     Abstract available


  12. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    PubMed     Text format     Abstract available


  13. ZHOU CF, Ma J, Huang L, Yi HY, et al
    Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.
    Oncogene. 2019;38:1256-1268.
    PubMed     Text format     Abstract available


    January 2019
  14. DONG P, Xiong Y, Yu J, Chen L, et al
    Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
    Oncogene. 2019 Jan 24. pii: 10.1038/s41388-019-0677.
    PubMed     Text format     Abstract available


  15. HUANG CC, Cheng SH, Wu CH, Li WY, et al
    Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.
    Oncogene. 2019 Jan 9. pii: 10.1038/s41388-018-0658.
    PubMed     Text format     Abstract available


  16. JING Y, Zhang Y, Zhu H, Zhang K, et al
    Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.
    Oncogene. 2019 Jan 7. pii: 10.1038/s41388-018-0644.
    PubMed     Text format     Abstract available


    December 2018
  17. MOTOHARA T, Masuda K, Morotti M, Zheng Y, et al
    An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Oncogene. 2018 Dec 19. pii: 10.1038/s41388-018-0637.
    PubMed     Text format     Abstract available


  18. LIU S, Yin P, Kujawa SA, Coon JS 5th, et al
    Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0612.
    PubMed     Text format     Abstract available


  19. GRABOSCH S, Bulatovic M, Zeng F, Ma T, et al
    Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles.
    Oncogene. 2018 Dec 5. pii: 10.1038/s41388-018-0581.
    PubMed     Text format     Abstract available


    November 2018
  20. ZHAO L, Wang W, Xu L, Yi T, et al
    Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0577.
    PubMed     Text format     Abstract available


  21. WUSTENHAGEN E, Boukhallouk F, Negwer I, Rajalingam K, et al
    The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.
    Oncogene. 2018;37:6275-6284.
    PubMed     Text format     Abstract available


    October 2018
  22. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
    Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
    PubMed     Text format     Abstract available


    September 2018
  23. ZHONG Y, Yang S, Wang W, Wei P, et al
    The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0512.
    PubMed     Text format     Abstract available


    August 2018
  24. SUN J, Cai X, Yung MM, Zhou W, et al
    miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0459.
    PubMed     Text format     Abstract available


    July 2018
  25. HODGKINSON K, Forrest LA, Vuong N, Garson K, et al
    GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0377.
    PubMed     Text format     Abstract available


  26. ZHOU W, Sun W, Yung MMH, Dai S, et al
    Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
    Oncogene. 2018;37:3981-3997.
    PubMed     Text format     Abstract available


    June 2018
  27. BAI M, Yang L, Liao H, Liang X, et al
    Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism.
    Oncogene. 2018 Jun 19. pii: 10.1038/s41388-018-0360.
    PubMed     Text format     Abstract available


  28. OZES AR, Pulliam N, Ertosun MG, Yilmaz O, et al
    Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.
    Oncogene. 2018;37:3589-3600.
    PubMed     Text format     Abstract available


    May 2018
  29. DONG P, Xiong Y, Yu J, Chen L, et al
    Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0347.
    PubMed     Text format     Abstract available


  30. SO D, Shin HW, Kim J, Lee M, et al
    Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0339.
    PubMed     Text format     Abstract available


  31. AL HABYAN S, Kalos C, Szymborski J, McCaffrey L, et al
    Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer.
    Oncogene. 2018 May 23. pii: 10.1038/s41388-018-0317.
    PubMed     Text format     Abstract available


  32. GABBASOV R, Xiao F, Howe CG, Bickel LE, et al
    NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0296.
    PubMed     Text format     Abstract available


  33. RADA M, Nallanthighal S, Cha J, Ryan K, et al
    Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
    Oncogene. 2018 May 17. pii: 10.1038/s41388-018-0297.
    PubMed     Text format     Abstract available


  34. BERNS K, Caumanns JJ, Hijmans EM, Gennissen AMC, et al
    ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
    Oncogene. 2018 May 15. pii: 10.1038/s41388-018-0300.
    PubMed     Text format     Abstract available


    April 2018
  35. WANG S, Li J, Xie J, Liu F, et al
    Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin beta4/SNAI1/SIRT3 signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0252.
    PubMed     Text format     Abstract available


  36. YU Y, Suryo Rahmanto Y, Lee MH, Wu PH, et al
    Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.
    Oncogene. 2018 Apr 11. pii: 10.1038/s41388-018-0241.
    PubMed     Text format     Abstract available


  37. DORAYAPPAN KDP, Wanner R, Wallbillich JJ, Saini U, et al
    Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
    Oncogene. 2018 Apr 11. pii: 10.1038/s41388-018-0189.
    PubMed     Text format     Abstract available


    March 2018
  38. PETA E, Sinigaglia A, Masi G, Di Camillo B, et al
    HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
    Oncogene. 2018;37:1654-1668.
    PubMed     Text format     Abstract available


    February 2018
  39. LIU F, Dai M, Xu Q, Zhu X, et al
    SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-kappaB-CD47 axis.
    Oncogene. 2018 Feb 12. pii: 10.1038/s41388-017-0119.
    PubMed     Text format     Abstract available


  40. MITAMURA T, Pradeep S, McGuire M, Wu SY, et al
    Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
    Oncogene. 2018;37:722-731.
    PubMed     Text format     Abstract available


  41. LIU Y, Zhou H, Zhu R, Ding F, et al
    SPSB3 targets SNAIL for degradation in GSK-3beta phosphorylation-dependent manner and regulates metastasis.
    Oncogene. 2018;37:768-776.
    PubMed     Text format     Abstract available


  42. LADANYI A, Mukherjee A, Kenny HA, Johnson A, et al
    Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
    Oncogene. 2018 Feb 5. pii: 10.1038/s41388-017-0093.
    PubMed     Text format     Abstract available


    January 2018
  43. AKHTER MZ, Sharawat SK, Kumar V, Kochat V, et al
    Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype.
    Oncogene. 2018 Jan 30. pii: 10.1038/s41388-017-0106.
    PubMed     Text format     Abstract available


  44. GHANNAM-SHAHBARI D, Jacob E, Kakun RR, Wasserman T, et al
    PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
    Oncogene. 2018 Jan 30. pii: 10.1038/s41388-017-0040.
    PubMed     Text format     Abstract available


  45. RUSSO A, Czarnecki AA, Dean M, Modi DA, et al
    PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0097.
    PubMed     Text format     Abstract available


  46. GRITHER WR, Divine LM, Meller EH, Wilke DJ, et al
    TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0043.
    PubMed     Text format     Abstract available


  47. NAGARAJ AB, Wang QQ, Joseph P, Zheng C, et al
    Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Oncogene. 2018;37:403-414.
    PubMed     Text format     Abstract available


  48. CORKERY DP, Clarke LE, Gebremeskel S, Salsman J, et al
    Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
    Oncogene. 2018;37:174-184.
    PubMed     Text format     Abstract available


    November 2017
  49. ZHONG Y, Yang J, Xu WW, Wang Y, et al
    KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
    Oncogene. 2017;36:6177-6189.
    PubMed     Text format     Abstract available


    October 2017
  50. WANG J, Kho DH, Zhou JY, Davis RJ, et al
    MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance.
    Oncogene. 2017;36:5939-5947.
    PubMed     Text format     Abstract available


    September 2017
  51. BIAN X, Gao J, Luo F, Rui C, et al
    PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  52. YOO JY, Yang WS, Lee JH, Kim BG, et al
    MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  53. RAMADOSS S, Sen S, Ramachandran I, Roy S, et al
    Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  54. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  55. GUO H, Zhu Q, Yu X, Merugu SB, et al
    Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization.
    Oncogene. 2017;36:5098-5109.
    PubMed     Text format     Abstract available


    July 2017
  56. ZHANG Y, Ren YJ, Guo LC, Ji C, et al
    Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1alpha axis.
    Oncogene. 2017;36:4171-4181.
    PubMed     Text format     Abstract available


    April 2017
  57. NIU N, Mercado-Uribe I, Liu J
    Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
    Oncogene. 2017 Apr 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: